Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

pembrolizumab 259 Cyclophosphamide 243 Specimen Handling 198 fludarabine 174 Magnetic Resonance Spectroscopy 173 Biopsy 147 Nivolumab 121 Carboplatin 99 Radiotherapy 92 Paclitaxel 88 venetoclax 82 Cisplatin 82 Gemcitabine 79 fludarabine phosphate 78 Injections 69 Ipilimumab 64 Dexamethasone 62 atezolizumab 59 Cetuximab 58 Bevacizumab 58 Radiation 56 Fluorouracil 56 Azacitidine 56 durvalumab 54 Radiosurgery 53 Temozolomide 47 Rituximab 44 Oxaliplatin 44 Docetaxel 44 Irinotecan 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Chemoradiotherapy, Adjuvant × 1 year × Clear all

NCT05667298 2026-05-11

OPERARADIO

University of Manitoba

Phase 1 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡